These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 22194486

  • 1. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
    Purysko AS, Remer EM, Coppa CP, Obuchowski NA, Schneider E, Veniero JC.
    AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
    Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, van Gulik TM, Phoa SS.
    AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
    [Abstract] [Full Text] [Related]

  • 3. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA, Pedro MT, Ruivo C, Semedo LC, Marques C, Alves FC.
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [Abstract] [Full Text] [Related]

  • 4. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.
    Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, Donato F, Colagrande S.
    Radiology; 2012 Feb; 262(2):520-9. PubMed ID: 22282184
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT, Iseman CM, Leyendecker JR, Shyknevsky I, Merkle EM, Taouli B.
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ, Kim BS, Kim MJ, Kim SH, de Campos RO, Hernandes M, Semelka RC.
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [Abstract] [Full Text] [Related]

  • 7. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
    Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF.
    AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
    [Abstract] [Full Text] [Related]

  • 8. Is gadoxetate disodium-enhanced MRI useful for detecting local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy?
    Watanabe H, Kanematsu M, Goshima S, Yoshida M, Kawada H, Kondo H, Moriyama N.
    AJR Am J Roentgenol; 2012 Mar; 198(3):589-95. PubMed ID: 22357997
    [Abstract] [Full Text] [Related]

  • 9. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
    Alamri TM, Cerny M, Al Shaikh M, Billiard JS, Olivié D, Chagnon M, Tang A.
    Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
    [Abstract] [Full Text] [Related]

  • 10. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ, Kim MJ, Choi JY, Park YN, Park MS, Kim KW.
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [Abstract] [Full Text] [Related]

  • 11. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.
    Kim MJ, Rhee HJ, Jeong HT.
    AJR Am J Roentgenol; 2012 Nov; 199(5):W575-86. PubMed ID: 23096201
    [Abstract] [Full Text] [Related]

  • 12. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT, Wang WP, Huang BJ, Ding H, Mao F, Si Q.
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [Abstract] [Full Text] [Related]

  • 13. Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics.
    Choi JY, Kim MJ, Park YN, Lee JM, Yoo SK, Rha SY, Seok JY.
    AJR Am J Roentgenol; 2011 Aug; 197(2):399-405. PubMed ID: 21785086
    [Abstract] [Full Text] [Related]

  • 14. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma.
    Park HJ, Byun JH, Kang JH, Kang HJ, Yu E, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN.
    Eur J Radiol; 2021 Jun; 139():109730. PubMed ID: 33930719
    [Abstract] [Full Text] [Related]

  • 15. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L, Morana G, Kirchin MA, Schneider G.
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [Abstract] [Full Text] [Related]

  • 16. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T.
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [Abstract] [Full Text] [Related]

  • 17. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY, Lee SS, Byun JH, Kim SY, Park SH, Shin YM, Lee MG.
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [Abstract] [Full Text] [Related]

  • 18. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
    Goshima S, Kanematsu M, Watanabe H, Kondo H, Mizuno N, Kawada H, Shiratori Y, Onozuka M, Moriyama N, Bae KT.
    Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A.
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [Abstract] [Full Text] [Related]

  • 20. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Cannella R, Rangaswamy B, Minervini MI, Borhani AA, Tsung A, Furlan A.
    AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.